| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/15/2012 | CN102356090A Combination gas vaccines and therapeutics |
| 02/15/2012 | CN102356089A Meningococcal fhbp polypeptides |
| 02/15/2012 | CN102355909A Combination therapy of an afucosylated antibody and one or more of the cytokines selected from human gm-csf, human m-csf and/or human il-3 |
| 02/15/2012 | CN102355908A Nanoparticle formulated glycolipid antigens for immunotherapy |
| 02/15/2012 | CN102355907A Treatment of a cancer using a combination of bendamustine and an anti-cd20 antibody |
| 02/15/2012 | CN102352365A Method for clearing away mycoplasma from pseudorabies vaccine strains |
| 02/15/2012 | CN102352347A Porcin circovirus type 2 (PCV2) recombinant baculovirus construction method and subunit vaccine preparation method thereof |
| 02/15/2012 | CN102352346A Novel-pathotype duck reovirus and attenuated vaccine thereof |
| 02/15/2012 | CN102352345A Preparation method of newcastle disease HI antigen |
| 02/15/2012 | CN102352338A Brucella shell as well as preparation method and application thereof |
| 02/15/2012 | CN102349997A Diagnosis and prevention of cancer cell invasion |
| 02/15/2012 | CN102349996A Human papilloma virus pharmaceutical composition and application thereof |
| 02/15/2012 | CN101732715B LSECtin及其融合蛋白在制备抑制癌细胞向肝转移药物中的应用 LSECtin and fusion proteins to inhibit cancer metastases in the manufacture of medicaments |
| 02/15/2012 | CN101590225B 百白破、A+C群脑膜炎球菌-b型流感嗜血杆菌结合疫苗 DPT, A + C meningococcal -b Haemophilus influenzae type conjugate vaccine |
| 02/15/2012 | CN101460620B 免疫刺激寡核苷酸及其药物用途 Immunostimulatory oligonucleotides and pharmaceutical use |
| 02/15/2012 | CN101172099B 稳定等渗的冻干蛋白质制剂 Stable lyophilized protein formulations isotonic |
| 02/14/2012 | US8114977 Proteins derived from white spot syndrome virus and uses thereof |
| 02/14/2012 | US8114971 Nucleotide sequences coding gramnegative bacterial lipoprotein for use in prevention and treatment of microorganismal infection; genetic vaccine |
| 02/14/2012 | US8114969 Immunotoxin derived from a recombinant human autoantibody and method of using thereof |
| 02/14/2012 | US8114968 Metalloproteinase-12 specific monoclonal antibody |
| 02/14/2012 | US8114966 Peptide-based passive immunization therapy for treatment of atherosclerosis |
| 02/14/2012 | US8114965 Compositions of PSMA antibodies |
| 02/14/2012 | US8114964 Anti-MCP-1 antibodies, compositions, methods and uses |
| 02/14/2012 | US8114852 N-linked glycosylation alteration in E1 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine |
| 02/14/2012 | US8114848 Immunomodulatory oligonucleotides |
| 02/14/2012 | US8114838 Methods for protecting dopaminergic neurons from stress and promoting proliferation and differentiation of oligodendrocyte progenitors by NRG-2 |
| 02/14/2012 | US8114618 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays |
| 02/14/2012 | US8114603 collecting a blood sample from the subject; andmeasuring the levels of Triggering Receptor Expressed on Myeloid cells (TREM-1) splice variant protein in sample, a decrease in the levels of TREM-1 splice variant indicates an inflammatory response |
| 02/14/2012 | US8114601 Highly conserved genes and their use to generate probes and primers for detection of microorganisms |
| 02/14/2012 | US8114586 Prevention and treatment of HCV infection employing antibodies directed against conformational and linear epitopes |
| 02/14/2012 | US8114585 Method for determining human immunodeficiency virus (HIV) coreceptor utilization by examining gp41 molecular determinants |
| 02/14/2012 | US8114582 Fluorescence polarization instruments and methods for detection of exposure to biological materials by fluorescence polarization immunoassay of saliva, oral or bodily fluids |
| 02/14/2012 | US8114419 Nucleic acid compositions for stimulating immune responses |
| 02/14/2012 | US8114418 Chimeric immunomodulatory compounds and methods of using the same—IV |
| 02/14/2012 | US8114417 Recombinant protective protein from Streptococcus pneumoniae |
| 02/14/2012 | US8114416 Modified oncolytic viruses |
| 02/14/2012 | US8114415 Method for producing temperature sensitive influenza A viruses |
| 02/14/2012 | US8114414 Compositions and methods for treatment of cervical cancer |
| 02/14/2012 | US8114412 T. cruzi-derived neurotrophic agents and methods of use therefor |
| 02/14/2012 | US8114411 Edwardsiella ictaluri E-ict-VL33 strain, vaccines thereof, and a method for protecting fishes using said vaccines |
| 02/14/2012 | US8114410 Composition and methods for the inhibition of membrane fusion by paramyxoviruses |
| 02/14/2012 | US8114409 Structural proteins of fish pancreatic disease virus and uses thereof |
| 02/14/2012 | US8114408 Peptide fragments reacting specifically with antibodies against highly pathogenic newcastle disease virus and uses thereof |
| 02/14/2012 | US8114407 Tyrosine kinase receptor epitope for use in identifying modulators for prevention and treatment of renal cancer |
| 02/14/2012 | US8114406 Peptides and their utility in modulation of behavior of cells expressing α3β1 integrins |
| 02/14/2012 | US8114405 Cancer vaccine based on brother of regulator of imprinted sites molecule (BORIS) |
| 02/14/2012 | US8114404 Method and composition for altering a B cell mediated pathology |
| 02/14/2012 | US8114403 Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
| 02/14/2012 | US8114402 Compositions and methods for the therapy and diagnosis of influenza |
| 02/14/2012 | US8114401 Chlamydia trachomatis antigens |
| 02/14/2012 | US8114400 Aza-bicyclic compounds and their use as stimulators of soluble guanylate cyclase |
| 02/14/2012 | US8114399 Targeting VEGF-B regulation of fatty acid transporters to modulate human diseases |
| 02/14/2012 | CA2516291C Dosage form having a saccharide matrix |
| 02/09/2012 | WO2012019188A2 Methods and compositions for the inhibition of fructokinase |
| 02/09/2012 | WO2012019125A2 Biomarkers for prostate cancer and methods for their detection |
| 02/09/2012 | WO2012019086A2 Inhibition of lar phosphatase to enhance therapeutic angiogenesis |
| 02/09/2012 | WO2012019024A2 Her3-binding molecules and immunoconjugates thereof |
| 02/09/2012 | WO2012019015A2 Methods and compositions for the treatment of myeloproliferative diseases and other proliferative diseases |
| 02/09/2012 | WO2012018973A1 Inactivated varicella zoster virus vaccines, methods of production, and uses thereof |
| 02/09/2012 | WO2012018877A2 Treating breast cancer with anti-il-19 antibody |
| 02/09/2012 | WO2012018856A2 Hiv vaccine therapy with concomitant antiviral monotherapy |
| 02/09/2012 | WO2012018813A2 Modified infectious laryngotracheitis virus (iltv) and uses thereof |
| 02/09/2012 | WO2012018801A2 Suppressing bone loss with anti-il-19 antibody |
| 02/09/2012 | WO2012018790A2 Dual variable domain immunoglobulins and uses thereof |
| 02/09/2012 | WO2012018771A1 Chronic lymphocytic leukemia (cll) biomarkers |
| 02/09/2012 | WO2012018767A2 Antibodies directed against il-17 |
| 02/09/2012 | WO2012018687A1 Covalent diabodies and uses thereof |
| 02/09/2012 | WO2012018628A1 Methods for inducing an immune response via buccal and/or sublingual administration of a vaccine |
| 02/09/2012 | WO2012018404A2 Use of her3 binding agents in prostate treatment |
| 02/09/2012 | WO2012018380A2 Compositions and methods for inducing immune tolerance |
| 02/09/2012 | WO2012018372A1 Mhc-less cells |
| 02/09/2012 | WO2012018284A1 Drug and method for the prophylaxis of hiv infection and for the prophylaxis and treatment of diseases caused by or associated with hiv, including aids |
| 02/09/2012 | WO2012018260A1 Epidermal growth factor receptor targeted immune therapy |
| 02/09/2012 | WO2012017327A2 Pharmaceutical composition and methods of treating and preventing the diseases caused by hiv or associated with hiv |
| 02/09/2012 | WO2012017324A2 Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases |
| 02/09/2012 | WO2012017323A2 Pharmaceutical composition and methods of treating and preventing the diseases caused by hiv or associated with hiv |
| 02/09/2012 | WO2012017322A2 Pharmaceutical composition and method of inhibiting of production or amplifying elimination of p24 protein |
| 02/09/2012 | WO2012017199A1 Fatty acid esters of carotenoid glucosides as colouring agents for foodstuffs |
| 02/09/2012 | WO2012017156A1 Concentrated human immunoglobulin composition |
| 02/09/2012 | WO2012017085A1 Antibodies against 6-sulfo-lacnac-positive human dendritic cells, and their use |
| 02/09/2012 | WO2012017082A2 Anti-la antibodies and their use for immunotargeting |
| 02/09/2012 | WO2012017033A1 Method of antigen loading for immunotherapy |
| 02/09/2012 | WO2012016978A1 Glycolipid for treatment of ischemia reperfusion injury |
| 02/09/2012 | WO2012016429A1 Compositions and methods for treating hepatitis virus infection |
| 02/09/2012 | WO2012016328A1 Portable soft gel droplet delivery device for treating poultry |
| 02/09/2012 | WO2012016315A1 A recombinant strain of the bacterium brucella spp and live vaccine against brucellosis |
| 02/09/2012 | WO2012016290A1 Modified hepatitis c virus proteins |
| 02/09/2012 | WO2011103417A3 Vectors expressing hiv antigens and gm-csf and related methods for generating an immune response |
| 02/09/2012 | US20120036589 Vaccine |
| 02/09/2012 | US20120035529 Tumor vascular marker-targeted vaccines |
| 02/09/2012 | US20120035073 Compositions and methods for the treatment of immune related diseases |
| 02/09/2012 | US20120034690 Cell lines producing blocking antibodies to human RANKL |
| 02/09/2012 | US20120034689 Mycobacterial antigens expressed during latency |
| 02/09/2012 | US20120034675 Tyrosinase mutant and methods of use thereof |
| 02/09/2012 | US20120034630 Circovirus Sequences Associated With Piglet Weight Loss Disease (PWD) |
| 02/09/2012 | US20120034609 Gene detection assay for improving the likelihood of an effective response to an egfr antagonist cancer therapy |
| 02/09/2012 | US20120034305 Solid dispersing vaccine composition for oral delivery |
| 02/09/2012 | US20120034294 Method of making small liposomes |
| 02/09/2012 | US20120034291 Nanoimprinting of silk fibroin structures for biomedical and biophotonic applications |
| 02/09/2012 | US20120034277 Resuscitation fluid |